Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 469309, 7 pages
http://dx.doi.org/10.1155/2014/469309
Research Article

Aaptamines from the Marine Sponge Aaptos sp. Display Anticancer Activities in Human Cancer Cell Lines and Modulate AP-1-, NF-κB-, and p53-Dependent Transcriptional Activity in Mouse JB6 Cl41 Cells

1Laboratory of Marine Natural Products Chemistry, G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far-East Branch of the Russian Academy of Sciences, Prospect 100 Let Vladivostoku 159, Vladivostok 690022, Russia
2Department of Oncology, Haematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald-Tumorzentrum, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany
3School of Natural Sciences, Far East Federal University, Sukhanova Street 8, Vladivostok 690950, Russia
4Tumor and Breast Center ZeTuP St. Gallen, Rorschacherstraße 150, 9006 St. Gallen, Switzerland

Received 28 February 2014; Revised 2 June 2014; Accepted 11 July 2014; Published 23 July 2014

Academic Editor: Jennifer Y. Zhang

Copyright © 2014 Sergey A. Dyshlovoy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. L. Larghi, M. L. Bohn, and T. S. Kaufman, “Aaptamine and related products. Their isolation, chemical syntheses, and biological activity,” Tetrahedron, vol. 65, no. 22, pp. 4257–4282, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. J. J. Bowling, H. K. Pennaka, K. Ivey et al., “Antiviral and anticancer optimization studies of the DNA-binding marine natural product aaptamine,” Chemical Biology and Drug Design, vol. 71, no. 3, pp. 205–215, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Aoki, D. Kong, H. Suna et al., “Aaptamine, a spongean alkaloid, activates p21 promoter in a p53-independent manner,” Biochemical and Biophysical Research Communications, vol. 342, no. 1, pp. 101–106, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. H. Jin, W. N. Zhao, Y. W. Zhang, M. Kobayashi, H. Q. Duan, and D. X. Kong, “Antiproliferative effect of aaptamine on human chronic myeloid leukemia K562 cells,” International Journal of Molecular Sciences, vol. 12, no. 11, pp. 7352–7359, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. S. A. Dyshlovoy, I. Naeth, S. Venz et al., “Proteomic profiling of germ cell cancer cells treated with aaptamine, a marine alkaloid with antiproliferative activity,” Journal of Proteome Research, vol. 11, no. 4, pp. 2316–2330, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. A. Dyshlovoy, S. Venz, L. K. Shubina et al., “Activity of aaptamine and two derivatives, demethyloxyaaptamine and isoaaptamine, in cisplatin-resistant germ cell cancer,” Journal of Proteomics, vol. 96, pp. 223–239, 2014. View at Publisher · View at Google Scholar
  7. L. K. Shubina, A. I. Kalinovsky, S. N. Fedorov et al., “Aaptamine alkaloids from the Vietnamese sponge Aaptos sp.,” Natural Product Communications, vol. 4, no. 8, pp. 1085–1088, 2009. View at Google Scholar · View at Scopus
  8. L. K. Shubina, T. N. Makarieva, S. A. Dyshlovoy, S. N. Fedorov, P. S. Dmitrenok, and V. A. Stonik, “Three new aaptamines from the marine sponge Aaptos sp. and their proapoptotic properties,” Natural Product Communications, vol. 5, no. 12, pp. 1881–1884, 2010. View at Google Scholar · View at Scopus
  9. S. A. Dyshlovoy, S. Fedorov, L. Shubina, F. Honecker, and V. Stonik, “Anticancer activity of aaptamine and its derivatives isolated from marine Vietnamese sponge Aaptos sp.,” Annals of Oncology, vol. 22, p. 33, 2011. View at Google Scholar
  10. S. A. Dyshlovoy, I. Naeth, S. Venz et al., “Aaptamine, demethyloxyaaptamine, and isoaaptamine: a proteomic- based screening of protein targets in cisplatin-resistant tumor cells,” Annals of Oncology, vol. 23, pp. 28–28, 2012. View at Google Scholar
  11. S. A. Dyshlovoy, I. Naeth, S. Venz et al., “Proteomic-based screening of protein targets of aaptamine, a marine alkaloid with antiproliferative activity,” Annals of Oncology, vol. 23, p. 32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. A. Baltrop, T. C. Owen, A. H. Cory, and J. G. Cory, “5-(3-carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3- (4-sulfophenyl)tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans as cell-viability indicators,” Bioorganic and Medicinal Chemistry Letters, vol. 1, no. 11, pp. 611–614, 1991. View at Publisher · View at Google Scholar · View at Scopus
  13. S. N. Fedorov, S. A. Dyshlovoy, L. K. Shubina, A. G. Guzii, A. S. Kuzmich, and T. N. Makarieva, “C11 cyclopentenone from the ascidian Diplosoma sp. prevents epidermal growth factor-induced transformation of JB6 cells,” Drugs and Therapy Studies, vol. 2, article e4, 2012. View at Google Scholar
  14. S. N. Fedorov, V. B. Krasokhin, L. K. Shubina, S. A. Dyshlovoy, N. H. Nam, and C. V. Minh, “The extracts of some marine invertebrates and algae collected off the coast waters of vietnam induce the inhibitory effects on the activator protein-1 transcriptional activity in JB6 Cl41 cells,” Journal of Chemistry, vol. 2013, Article ID 896709, 6 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. B. C. Mckay, C. Becerril, and M. Ljungman, “P53 plays a protective role against UV- and cisplatin-induced apoptosis in transcription-coupled repair proficient fibroblasts,” Oncogene, vol. 20, no. 46, pp. 6805–6808, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Eferl and E. F. Wagner, “AP-1: a double-edged sword in tumorigenesis,” Nature Reviews Cancer, vol. 3, no. 11, pp. 859–868, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. M. R. Young, J. J. Li, M. Rincón et al., “Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 17, pp. 9827–9832, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. L. R. Bernstein and N. H. Colburn, “AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells,” Science, vol. 244, no. 4904, pp. 566–569, 1989. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Tulchinsky, “Fos family members: regulation, structure and role in oncogenic transformation,” Histology and Histopathology, vol. 15, no. 3, pp. 921–928, 2000. View at Google Scholar · View at Scopus
  20. V. C. Foletta, D. H. Segal, and D. R. Cohen, “Transcriptional regulation in the immune system: all roads lead to AP-1,” Journal of Leukocyte Biology, vol. 63, no. 2, pp. 139–152, 1998. View at Google Scholar · View at Scopus
  21. H.-M. Shen and V. Tergaonkar, “NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy,” Apoptosis, vol. 14, no. 4, pp. 348–363, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Oeckinghaus and S. Ghosh, “The NF-kappaB family of transcription factors and its regulation,” Cold Spring Harbor Perspectives in Biology, vol. 1, no. 4, Article ID a000034, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Shaulian and M. Karin, “AP-1 in cell proliferation and survival,” Oncogene, vol. 20, no. 19, pp. 2390–2400, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Shaulian, “AP-1 - The Jun proteins: oncogenes or tumor suppressors in disguise?” Cellular Signalling, vol. 22, no. 6, pp. 894–899, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Ameyar, M. Wisniewska, and J. B. Weitzman, “A role for AP-1 in apoptosis: the case for and against,” Biochimie, vol. 85, no. 8, pp. 747–752, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. A. S. Liss, R. Tiwari, J. Kralova, and H. R. Bose Jr., “Cell transformation by v-Rel reveals distinct roles of AP-1 family members in Rel/NF-B oncogenesis,” Oncogene, vol. 29, no. 35, pp. 4925–4937, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Bhoumik and Z. Ronai, “ATF2: a transcription factor that elicits oncogenic or tumor suppressor activities,” Cell Cycle, vol. 7, no. 15, pp. 2341–2345, 2008. View at Google Scholar · View at Scopus
  28. R. Sen and S. T. Smale, “Selectivity of the NF-{kappa}B response.,” Cold Spring Harbor Perspectives in Biology, vol. 2, no. 4, Article ID a000257, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Cadoret, F. Bertrand, S. Baron-Delage et al., “Down-regulation of NF-κB activity and NF-κB p65 subunit expression by ras and polyoma middle T oncogenes in human colonic Caco-2 cells,” Oncogene, vol. 14, no. 13, pp. 1589–1600, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Kucharczak, M. J. Simmons, Y. Fan, and C. Gélinas, “To be, or not to be: NF-κB is the answer: role of Rel/NF-κB in the regulation of apoptosis,” Oncogene, vol. 22, no. 56, pp. 8961–8982, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Kasibhatla, T. Brunner, L. Genestier, F. Echeverri, A. Mahboubi, and D. R. Green, “DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1,” Molecular Cell, vol. 1, no. 4, pp. 543–551, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. S. K. Manna, N. K. Sah, and B. B. Aggarwal, “Protein tyrosine kinase p56(lck) is required for ceramide-induced but not tumor necrosis factor-induced activation of NF-κB, AP-1, JNK, and apoptosis,” The Journal of Biological Chemistry, vol. 275, no. 18, pp. 13297–13306, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Mangolini, M. Bogo, C. Durante et al., “NF-κB activation is required for apoptosis in fibrocystin/polyductin-depleted kidney epithelial cells,” Apoptosis, vol. 15, no. 1, pp. 94–104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Chiu, P. Angel, and M. Karin, “Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun,” Cell, vol. 59, no. 6, pp. 979–986, 1989. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Passegué, W. Jochum, M. Schorpp-Kistner, U. Möhle-Steinlein, and E. F. Wagner, “Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking JunB expression in the myeloid lineage,” Cell, vol. 104, no. 1, pp. 21–32, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Le-Niculescu, E. Bonfoco, Y. Kasuya, F. Claret, D. R. Green, and M. Karin, “Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death,” Molecular and Cellular Biology, vol. 19, no. 1, pp. 751–763, 1999. View at Google Scholar · View at Scopus
  37. T. Kondo, T. Matsuda, T. Kitano et al., “Role of c-jun expression increased by heat shock- and ceramide-activated caspase-3 in HL-60 cell apoptosis: possible involvement of ceramide in heat shock-induced apoptosis,” The Journal of Biological Chemistry, vol. 275, no. 11, pp. 7668–7676, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Yan, G. X. Zhang, M. S. Williams et al., “TCR stimulation upregulates MS4a4B expression through induction of AP-1 transcription factor during T cell activation,” Molecular Immunology, vol. 52, no. 2, pp. 71–78, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Lau and Z. A. Ronai, “ATF2 - at the crossroad of nuclear and cytosolic functions,” Journal of Cell Science, vol. 125, no. 12, pp. 2815–2824, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Leppä, M. Eriksson, R. Saffrich, W. Ansorge, and D. Bohmann, “Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells,” Molecular and Cellular Biology, vol. 21, no. 13, pp. 4369–4378, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Gopalakrishnan and A. Tony Kong, “Anticarcinogenesis by dietary phytochemicals: cytoprotection by Nrf2 in normal cells and cytotoxicity by modulation of transcription factors NF-κB and AP-1 in abnormal cancer cells,” Food and Chemical Toxicology, vol. 46, no. 4, pp. 1257–1270, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Berry, M. Goodwin, C. L. Moran, and T. C. Chambers, “AP-1 activation and altered AP-1 composition in association with increased phosphorylation and expression of specific Jun and Fos family proteins induced by vinblastine in KB-3 cells,” Biochemical Pharmacology, vol. 62, no. 5, pp. 581–591, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Fan, M. E. Goodwin, M. J. Birrer, and T. C. Chambers, “The c-Jun NH2-terminal protein kinase/AP-1 pathway is required for efficient apoptosis induced by vinblastine,” Cancer Research, vol. 61, no. 11, pp. 4450–4458, 2001. View at Google Scholar · View at Scopus
  44. A. Gopalakrishnan, C. Xu, S. S. Nair, C. Chen, V. Hebbar, and A. T. Kong, “Modulation of activator protein-1 (AP-1) and MAPK pathway by flavonoids in human prostate cancer PC3 cells,” Archives of Pharmacal Research, vol. 29, no. 8, pp. 633–644, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. S.-H. Lee, J. H. Bahn, N. C. Whitlock, and S. J. Baek, “Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways,” Oncogene, vol. 29, no. 37, pp. 5182–5192, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. A. S. Kuzmich, S. N. Fedorov, V. V. Shastina et al., “The anticancer activity of 3- and 10-bromofascaplysins is mediated by caspase-8, -9, -3-dependent apoptosis,” Bioorganic and Medicinal Chemistry, vol. 18, no. 11, pp. 3834–3840, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. L. K. Shubina, S. N. Fedorov, O. S. Radchenko et al., “Desmethylubiquinone Q2 from the Far-Eastern ascidian Aplidium glabrum: Structure and synthesis,” Tetrahedron Letters, vol. 46, no. 4, pp. 559–562, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. S. N. Fedorov, O. S. Radchenko, L. K. Shubina et al., “Evaluation of cancer-preventive activity and structure-activity relationships of 3-demethylubiquinone Q2, isolated from the ascidian Aplidium glabrum, and its synthetic analogs,” Pharmaceutical Research, vol. 23, no. 1, pp. 70–81, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. S. N. Fedorov, O. S. Radchenko, L. K. Shubina et al., “Anticancer activity of 3-demethylubiquinone Q2. In vivo experiments and probable mechanism of action,” Anticancer Research, vol. 28, no. 2, pp. 927–932, 2008. View at Google Scholar · View at Scopus
  50. S. N. Fedorov, L. K. Shubina, A. M. Bode, V. A. Stonik, and Z. G. Dong, “Dactylone inhibits epidermal growth factor-induced transformation and phenotype expression of human cancer cells and induces G1-S arrest and apoptosis,” Cancer Research, vol. 67, no. 12, pp. 5914–5920, 2007. View at Publisher · View at Google Scholar · View at Scopus